


Clinical Research Advancement Revenue
Biotechnology Research • Outram, Central Region, Singapore • 1-10 Employees
Clinical Research Advancement revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at Clinical Research Advancement
Kassime Calhoun
Director of Clinical Systems
Company overview
| Headquarters | 133 New Bridge Rd, 10-03, Singapore, 059413, SG |
| Website | |
| NAICS | 541714 |
| Keywords | International Business, Diagnostics, Oncology, Precision Medicine, Decentralized Trail Support, Global Recruitment And Retention Strategies |
| Founded | 2010 |
| Employees | 1-10 |
About Clinical Research Advancement
Clinical Research Advancement is committed to advancing healthcare through the innovative and seamless execution of Global Clinical Research initiatives. As global recruitment and retention specialists, our focus is health equity through inclusive research. We assist pharmaceutical companies and healthcare organizations in accessing and engaging minority communities so that research is more inclusive. expertise spans multiple therapeutic indications, our specialties include Oncology, Respiratory, Cardiovascular, Endocrinology, Infectious and Rare diseases. We offer a "full service" CRO experience across all phases of Clinical development.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Clinical Research Advancement has never raised funding before.
Clinical Research Advancement Tech Stack
Discover the technologies and tools that power Clinical Research Advancement's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
Analytics
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Miscellaneous
Security
Programming languages
Blogs
Hosting
Frequently asked questions
4.8
40,000 users



